Dilantin Infusion Rate
The maximum recommended intravenous infusion rate for Dilantin (phenytoin) is 50 mg/min, with a loading dose of 18 mg/kg. 1
Dosing and Administration
Loading Dose:
- 18 mg/kg IV is the standard loading dose 1, 2
- Administer at a maximum rate of 50 mg/min 1, 2
- This regimen achieves therapeutic serum levels (10-20 mcg/mL) for up to 24 hours in most patients 2
Critical Safety Considerations
The 50 mg/min rate limit exists to prevent life-threatening cardiovascular complications, including:
Slower infusion rates are mandatory for high-risk patients:
- Elderly patients: Reduce rate by 25-50% 4
- Cardiovascular comorbidities: Use slower rates with continuous cardiac monitoring 3
- Renal or hepatic disease: Reduce rate by 25-50% 4
- Hypoalbuminemia: Reduce rate by 25-50% 4
In these populations, consider 20-40 mg/min as a safer alternative 3, 4.
Practical Administration Details
Required monitoring during infusion:
- Continuous cardiac rhythm monitoring (telemetry preferred) 5
- Blood pressure every 15 minutes 5
- IV site assessment for extravasation injuries 1
Technical requirements:
Alternative Dosing Strategy
An alternative loading approach divides the dose into three injections of maximum 400 mg each, given 2 hours apart 1, 6. This method:
- Reduces cardiovascular risk
- Still achieves therapeutic levels within 6 hours in 90% of patients 6
- May be preferable in high-risk patients
Important Clinical Pitfalls
Do NOT exceed 50 mg/min in standard patients - case reports demonstrate that rapid infusion rates (>50 mg/min) are the major cause of phenytoin-related mortality 3. Deaths have occurred from ventricular fibrillation and cardiac arrest when this rate is exceeded.
Fosphenytoin is safer for rapid loading: If faster administration is needed, fosphenytoin can be given at 150 PE/min (phenytoin equivalents per minute) with fewer cardiovascular adverse effects 1, 4. This is three times faster than phenytoin and has become preferred in many emergency settings.
Overweight patients require adjusted dosing: For patients weighing >120% of ideal body weight, use adjusted body weight rather than actual body weight to calculate the loading dose to avoid supratherapeutic levels 7.